Literature DB >> 8439453

Clinical and biochemical studies in an American child with sialuria.

D M Krasnewich1, F Tietze, W Krause, R Pretzlaff, D A Wenger, V Diwadkar, W A Gahl.   

Abstract

Sialuria is a rare inborn error of sialic acid (NeuAc) metabolism resulting from failure of CMP-NeuAc to adequately feedback inhibit the rate-limiting enzyme in sialic acid synthesis, UDP N-acetylglucosamine (UDP-GlcNAc) 2-epimerase. We describe the fourth reported sialuria patient, T.W., whose clinical features include developmental delay, coarse facies, and massive urinary excretion of sialic acid. Biochemical studies of T.W. fibroblasts revealed a 200-fold increase in free NeuAc content compared with normal. Bound NeuAc was only slightly elevated. The free NeuAc was predominantly in the cytosol fraction of fibroblasts after differential centrifugation, with only 4% of the free NeuAc content in other (nuclear, granular, and microsomal) cellular compartments. CMP-NeuAc inhibited UDP-GlcNAc 2-epimerase by 80% in normal fibroblasts but inhibited the epimerase of T.W. (sialuria) cells by only 13%. Cytidine feeding of sialuria fibroblasts decreased the intracellular free NeuAc content by 47%; this was accompanied by a fourfold increase in CMP-NeuAc, which may be sufficient to feedback inhibit the mutant epimerase and reduce free NeuAc production. Cytoplasmic pH was determined by the pH sensitive fluorescent indicator 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein, pentaacetoxymethylester (BCECF/AM) using the H+ equilibration method. The intracellular pH of sialuria fibroblasts, 7.18 +/- 0.04, was not found to be significantly different from that of normal cells (7.19 +/- 0.08).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439453     DOI: 10.1006/bmmb.1993.1010

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  7 in total

1.  Dominant inheritance of sialuria, an inborn error of feedback inhibition.

Authors:  J G Leroy; R Seppala; M Huizing; G Dacremont; H De Simpel; R N Van Coster; E Orvisky; D M Krasnewich; W A Gahl
Journal:  Am J Hum Genet       Date:  2001-04-18       Impact factor: 11.025

2.  Sialuria: Ninth Patient Described Has a Novel Mutation in GNE.

Authors:  Noelia Nunez Martinez; Michelle Lipke; Jacqueline Robinson; Bridget Wilcken
Journal:  JIMD Rep       Date:  2018-06-20

3.  Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme.

Authors:  R Seppala; V P Lehto; W A Gahl
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

4.  Clinical course and biochemistry of sialuria.

Authors:  G M Enns; R Seppala; T J Musci; K Weisiger; L D Ferrell; D A Wenger; W A Gahl; S Packman
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

5.  New observation of sialuria prompts detection of liver tumor in previously reported patient.

Authors:  Neena L Champaigne; Jules G Leroy; Priya S Kishnani; Jochen Decaestecker; Edwin Steenkiste; Alka Chaubey; Jiarui Li; Chris Verslype; Jo Van Dorpe; Laura Pollard; Jennifer L Goldstein; Louis Libbrecht; Monica Basehore; Nansheng Chen; Heping Hu; Tim Wood; Michael J Friez; Marjan Huizing; Roger E Stevenson
Journal:  Mol Genet Metab       Date:  2016-04-16       Impact factor: 4.797

6.  Allele-specific silencing of the dominant disease allele in sialuria by RNA interference.

Authors:  Riko D Klootwijk; Paul J M Savelkoul; Carla Ciccone; Irini Manoli; Natasha J Caplen; Donna M Krasnewich; William A Gahl; Marjan Huizing
Journal:  FASEB J       Date:  2008-07-24       Impact factor: 5.191

Review 7.  UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.

Authors:  Stephan Hinderlich; Wenke Weidemann; Tal Yardeni; Rüdiger Horstkorte; Marjan Huizing
Journal:  Top Curr Chem       Date:  2015
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.